ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Systolic Blood Pressure, Cardiovascular Mortality, and All-Cause Mortality in Normoglycemia, Prediabetes, and Diabetes

Chen, Chao-Lei; Liu, Lin; Huang, Jia-Yi; Yu, Yu-Ling; Lo, Kenneth; Huang, Yu-Qing*; Feng, Ying-Qing*广东省人民医院; 广东省心血管病研究所
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy2020DOI: 10.2147/DMSO.S260990
4被引6阅读
引用收藏
分享

摘要

Background: The optimal blood pressure (BP) level for diabetic patients remains controversial, while studies provided limited evidence on BP management for individuals with normoglycemia or prediabetes. We aimed to investigate the associations between systolic blood pressure (SBP) and all-cause and cardiovascular (CVD) mortality among US adults with different glycemic profiles. @@@ Methods: We used data from the 1999-2014 National Health and Nutrition Examination Survey (NHANES, n=40,046) with comprehensive baseline examination and follow-up assessment. Restricted cubic spline analysis was performed to examine dose-response relationship between SBP and mortality risk. Cox regression models were used to estimate hazard ratios of all-cause mortality and CVD mortality for SBP categories. @@@ Results: U-shaped associations between SBP and all-cause mortality were observed regardless of glucose status. The relationship between SBP and CVD mortality was found to be U-shaped only in normoglycemic participants. The lowest mortality risk of optimal SBP (mmHg) by group was 115-120 (normoglycemia), 120-130 (prediabetes), and 125-135 (diabetes). When compared with the reference group, SBP < 100 mmHg was significantly associated with 49% (HR=1.49, 95% CI: 1.13-1.96), 57% (1.57, 1.07-2.3), and 59% (1.59, 1.12-2.25) higher all-cause mortality risk in people with normoglycemia, prediabetes, and diabetes, respectively. The multivariable-adjusted HRs of all-cause mortality for SBP >= 150 mmHg were 1.51 (1.25-1.82), 1.56 (1.27-1.93), and 1.33 (1.08-1.64), respectively. As for CVD mortality, the multivariable-adjusted HRs were 2.85 (1.29-6.33) for SBP <100 mmHg and 2.71 (1.56-4.69) for SBP >= 150 mmHg in normoglycemia; HR was 1.66 (1.05-2.63) for SBP >= 150 mmHg in diabetic patients. @@@ Conclusion: U-shaped relationships between SBP and all-cause mortality were observed regardless of diabetes status. The optimal SBP range was gradually higher with worsening glucose status.

学科与关键词

关键词
systolic blood pressuremortalitynormoglycemiaprediabetesdiabetes mellitus
相关
加载中…
  • Relationship of Glycated Hemoglobin A1c with All-Cause and Cardiovascular Mortality among Patients with Hypertension
    Zeng, Ruixiang; Zhang, Yuzhuo; Xu, Junpeng; Kong, Yongjie; Tan, Jiawei; Guo, Liheng; Zhang, Minzhou*Journal of Clinical Medicine, 2023, 12(7): 2615.被引 1
  • Prehypertension and risk for all-cause and cardiovascular mortality by diabetes status: results from the national health and nutrition examination surveys
    Huang, Yu-Qing; Liu, Lin; Huang, Jia-Yi; Lo, Kenneth; Chen, Chao-Lei; Yu, Yu-Ling; Li, Jie*; Feng, Ying-Qing*Annals of Translational Medicine, 2020, 8(6): 323.被引 6
  • The Influence of baseline glycemic status on the effects of intensive blood pressure lowering: Results from the STEP randomized trial
    Yang, Ruixue; Wang, Yixuan; Tong, Anli; Yu, Jing; Zhao, Dechao; Cai, Jun*European Journal of Internal Medicine, 2023, 113: 75-82.
查看全部 →

发表信息

论文状态
公开发表
期刊
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
发表日期
2020
卷期
第 13 卷
页码
2375-2388
DOI
10.2147/DMSO.S260990
期刊收录
NSL.SCIE
期刊等级
4区
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou [201604020143, 201604020018, 201604020186, 201803040012]; National Key Research and Development Program of China [2017YFC1307603, 2016YFC1301305]; Key Area R&D Program of Guangdong Province [2019B020227005]

作者

  • C

    Chen, Chao-Lei (第一作者)

    cardiovasc inst,guangdong · guangdong prov peoples hosp

  • L

    Liu, Lin

    cardiovasc inst,guangdong · guangdong prov peoples hosp

查看全部 7 位作者收起作者
  • H

    Huang, Jia-Yi

    cardiovasc inst,guangdong · guangdong prov peoples hosp

  • Y

    Yu, Yu-Ling

    cardiovasc inst,guangdong · guangdong prov peoples hosp

  • L

    Lo, Kenneth

    cardiovasc inst,guangdong · guangdong prov peoples hosp

  • H

    Huang, Yu-Qing (通讯)

    cardiovasc inst,guangdong · guangdong prov peoples hosp

  • F

    Feng, Ying-Qing (通讯)

    cardiovasc inst,guangdong · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417